Business Wire IndiaBeyondSquare Solutions, a software products firm headquartered in Bengaluru and PwC India today announced a strategic partnership to drive adoption of digital transformation in the finance function for…
Business Wire India Kinaxis® Inc. (TSX: KXS), a global leader in end-to-end supply chain orchestration, today announced that Mahindra & Mahindra Ltd. (M&M), one of India’s leading automotive companies, has…
Business Wire India Starting October 3rd, avail exciting offers on fashion, luxury, and beauty from leading global and Indian brands across categories on all three platforms Wish listers get early…
Business Wire India Approximately 80% fast charging network coverage 28 charging partners onboarded including leading players of India Over 17 million green kilometers planned via the app Approximately 30,000 green…
Business Wire IndiaWNS (Holdings) Limited (NYSE: WNS), a leading provider of global digital-led Business Process Management (BPM) solutions, and Uniqus Consultech Inc. (Uniqus), a tech-enabled global platform that offers consulting…
Business Wire India FPT Software recently received the Job Creation Award—Vietnam at the ESGBusiness Awards 2024, marking its debut win in this award. This accolade underscores the company’s steadfast commitment…
Business Wire India ThoughtSpot, the AI-Powered Analytics Company, today announced that the Company has appointed Ketan Karkhanis as Chief Executive Officer. Ketan is joining ThoughtSpot from Salesforce, where he has…
Business Wire India R Systems International Limited, a global leader in digital product engineering, today announced the launch of our groundbreaking Resilience Engineering model, which combines Chaos Engineering with DRaaS.…
Business Wire India Symbiosis Skills and Professional University (SSPU), Maharashtra’s first Skill University concluded its 5th Convocation Ceremony on Saturday, 28th September 2024 at its Kiwale Campus. Prof. T. G.…
Business Wire India Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) announced that the phase 3 comparative clinical trial for the investigational Perjeta® (pertuzumab) biosimilar HLX11 met the primary…
dssenthil